HCV High Cost Drugs. Unless otherwise specified by EOHHS, Non-HCV High Cost Drugs are drugs that have a typical treatment cost greater than $200,000 per patient per year, an FDA orphan designation, and treat an applicable condition that affects fewer than 20,000 individuals nationwide. Non-Medical Programs and Services – an item or service, including an Enrollee Incentive, the Contractor decides to make available to its Enrollees, which is not a TCOC Included Service or any other MassHealth covered service. The Contractor must use its own funds to provide such Non- Medical Programs and Services and may not include the costs of such Non-Medical Programs and Services as medical service costs or administrative costs for purposes of any MassHealth rate or benchmark development, as further specified by EOHHS. Ombudsman – a neutral entity that has been contracted by MassHealth to assist Enrollees (including their families, caregivers, representatives and/or advocates) with information, issues, or concerns. Operational Start Date – the date on which the Contractor starts to provide the activities described in this Contract to Enrollees, March 1, 2018.
Appears in 5 contracts
Samples: Primary Care Accountable Care Organization Contract, Primary Care Accountable Care Organization Contract, Primary Care Accountable Care Organization Contract
